Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

South African study using J&J vaccine will resume

South African study using J&J vaccine will resume

SOUTH African researchers will tomorrow resume a study further evaluating the efficacy of Johnson & Johnson's COVID-19 vaccine in the field, after it was temporarily suspended along with use of the shot in the United States. U.S. regulators recommended pausing the use of the single-shot earlier this month due to extremely rare cases of blood clots but on Friday said the United States could restart vaccinations. Europe's drug regulator has backed its overall benefits against any risk. The Sisonke study is being carried out by the National Department of Health, South African Medical Research Council and Johnson & Johnson among…
Read More